These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10579830)

  • 21. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
    Ko J; Jang SW; Kim YS; Kim IS; Sung HJ; Kim HH; Park JY; Lee YH; Kim J; Na DS
    FASEB J; 2004 May; 18(7):890-2. PubMed ID: 15001559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo.
    Bonville CA; Lau VK; DeLeon JM; Gao JL; Easton AJ; Rosenberg HF; Domachowske JB
    J Virol; 2004 Aug; 78(15):7984-9. PubMed ID: 15254170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.
    Zoffmann S; Chollet A; Galzi JL
    Mol Pharmacol; 2002 Sep; 62(3):729-36. PubMed ID: 12181451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1.
    Liang M; Mallari C; Rosser M; Ng HP; May K; Monahan S; Bauman JG; Islam I; Ghannam A; Buckman B; Shaw K; Wei GP; Xu W; Zhao Z; Ho E; Shen J; Oanh H; Subramanyam B; Vergona R; Taub D; Dunning L; Harvey S; Snider RM; Hesselgesser J; Morrissey MM; Perez HD
    J Biol Chem; 2000 Jun; 275(25):19000-8. PubMed ID: 10748002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice.
    Morteau O; Castagliuolo I; Mykoniatis A; Zacks J; Wlk M; Lu B; Pothoulakis C; Gerard NP; Gerard C
    Gastroenterology; 2002 Mar; 122(3):725-33. PubMed ID: 11875005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1.
    Broxmeyer HE; Cooper S; Hangoc G; Gao JL; Murphy PM
    J Exp Med; 1999 Jun; 189(12):1987-92. PubMed ID: 10377195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.
    Topham PS; Csizmadia V; Soler D; Hines D; Gerard CJ; Salant DJ; Hancock WW
    J Clin Invest; 1999 Dec; 104(11):1549-57. PubMed ID: 10587518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
    Gladue RP; Tylaska LA; Brissette WH; Lira PD; Kath JC; Poss CS; Brown MF; Paradis TJ; Conklyn MJ; Ogborne KT; McGlynn MA; Lillie BM; DiRico AP; Mairs EN; McElroy EB; Martin WH; Stock IA; Shepard RM; Showell HJ; Neote K
    J Biol Chem; 2003 Oct; 278(42):40473-80. PubMed ID: 12909630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
    J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice.
    Zhang Y; Yoneyama H; Wang Y; Ishikawa S; Hashimoto S; Gao JL; Murphy P; Matsushima K
    J Natl Cancer Inst; 2004 Feb; 96(3):201-9. PubMed ID: 14759987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels.
    Andjelkovic AV; Pachter JS
    J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of specific polyclonal antibodies to a C-C chemokine receptor, CCR1, and determination of CCR1 expression on various types of leukocytes.
    Su SB; Mukaida N; Wang J; Nomura H; Matsushima K
    J Leukoc Biol; 1996 Nov; 60(5):658-66. PubMed ID: 8929558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
    Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
    Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
    Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of a rat macrophage inflammatory protein-1alpha receptor.
    Waller A; Nayee P; Czaplewski LG
    J Hematother Stem Cell Res; 2000 Oct; 9(5):703-9. PubMed ID: 11091494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice.
    Gladue RP; Cole SH; Roach ML; Tylaska LA; Nelson RT; Shepard RM; McNeish JD; Ogborne KT; Neote KS
    J Immunol; 2006 Mar; 176(5):3141-8. PubMed ID: 16493073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
    Lean JM; Murphy C; Fuller K; Chambers TJ
    J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
    Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
    Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.